- Nascent Journeys To Discovery
A glimpse into the minds of three young faculty members: immunologist Morgan Huse, biostatistician Ronglai Shen, and medical oncologist Diane Reidy-Lagunes. - Oncologist Paul Sabbatini Talks About New Strategies to Treat Ovarian Cancer
Medical oncologist Paul Sabbatini, a specialist in treating gynecologic cancers, leads a clinical research program seeking to improve treatments for ovarian cancer by harnessing the power of the immune system. - 32nd Annual Memorial Sloan-Kettering Convocation
Academic Convocation honored students receiving PhD degrees for work conducted in Memorial Sloan-Kettering’s laboratories; younger Memorial Sloan-Kettering physicians, scientists, and postdoctoral research fellows; and established clinicians and investigators from the Center and beyond. - Samuel and May Rudin Awards Recognize Nursing Excellence
At the 2011 Samuel and May Rudin Awards for Excellence in Nursing Ceremony, five distinguished Memorial Sloan-Kettering nurses and one unit assistant were recognized for exemplary service in patient care, education, and research. - Memorial Sloan-Kettering Celebrates Ten Years of Fertility-Preserving Surgical Procedure
Memorial Sloan-Kettering physicians Yukio Sonoda and Nadeem Abu-Rustum were joined by cancer survivors and their children to celebrate 10 years of Memorial Sloan-Kettering’s radical trachelectomy program. - Former New York Yankees Manager Joe Torre Shares Cancer Experience at Memorial Sloan-Kettering Survivorship Celebration
Cancer survivors and staff gathered on June 22 to celebrate National Cancer Survivors Day. The keynote speaker, baseball legend Joe Torre, praised the care provided by Memorial Sloan-Kettering and spoke about being a survivor. - Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer
In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan-Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors. - Memorial Sloan-Kettering Researchers Discover How Gene Mutation Contributes to Leukemia
A study led by researchers at Memorial Sloan-Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells. - Biologist Scott Lowe Joins Memorial Sloan-Kettering
Scott W. Lowe has joined Memorial Sloan-Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan-Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center. - Pediatric Patients Celebrate High School Graduations at Annual Convocation
Memorial Sloan-Kettering Cancer Center Department of Pediatrics patients celebrate high school graduations at the fifth annual Convocation.
Inside MSKCC
|
©2013 Memorial Sloan-Kettering Cancer Center